Klox Launches Its Commercial Activities for LumiHeal(TM) in Europe for the Treatment of Chronic, Acute and Surgical Wounds Along With Burns

LAVAL, Canada, May 14, 2015 (GLOBE NEWSWIRE) -- Klox Technologies Inc. ('Klox'), today announced the formal launch of its lead product, LumiHealTM for the treatment of chronic, acute and surgical wounds along with burns at the annual European Wound Management Association ('EWMA') Conference in London, United Kingdom. "We are very excited to bring this pioneering technology to the wound care market - LumiHealTM addresses an unmet need in the market by having bactericidal and healing properties, along with being a single, and easy to use product," stated Mr. Todd Martensen, Chief Commercial Officer.

At the EWMA Conference, Dr. Marco Romanelli, MD, PhD, Associate Professor of Dermatology at the School of Medicine, University of Pisa, and Chief of the Wound Healing Research Unit, and President Elect of the World Union of Wound Healing Societies, will be chairing a symposium in regards to Klox's lead product LumiHealTM with the participation of Dr. Andreas Nikolis, MD, MSc and Dr. Denis Vezina, PhD. "This is an adaptive technology that can really make a difference in the way we manage and treat all types of wounds," stated Dr. Marco Romanelli. "LumiHealTM represents a significant innovation in a space with limited innovation - we are eager to embrace LumiHealTM within the market."

In addition to the symposium, Klox will be orally presenting: "Evaluating the effect of BioPhotonic therapy on physical and histologic parameters in an incisional rat model," and "New technologies in wound care: Klox Technologies" along with a poster presentation of the "Evaluation of the Klox BioPhotonic therapy system on grade II–III pressure sores."

About Klox:

Klox is a specialty pharmaceutical company focused on developing and commercializing products based on our proprietary BioPhotonic technology platform to address skin and soft tissue disorders. We have a multi-franchise platform focusing on indications across Dermatology, Wound Care, and Oral Health.

About EWMA:

The European Wound Management Association ('EWMA') was founded in 1991, and the association works to promote the advancement of education and research into native epidemiology, pathology, diagnosis, prevention and management of wounds of all aetiologies. EWMA is an umbrella organization linking wound management associations across Europe and a multidisciplinary group bringing together individuals and organizations interested in wound management. EWMA works to reach its objectives by being an educational resource, organizing conferences, contributing to international projects related to wound management, actively supporting the implementation of existing knowledge within wound management and providing information on all aspects of wound management.

CONTACT: 866-653-5569 Info@kloxtechnologies.comSource:KLOX Technologies Inc.